Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Cash Flow from Operations

Arena Pharmaceutical Cash Flow from Operations Chart (ARNA)

Arena Pharmaceutical annual/quarterly Cash Flow from Operations from 2000 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Arena Pharmaceutical Cash Flow from Operations for the quarter ending September 09, 2018 was $-31m a 40.98% decrease of -13m year over year
  • Arena Pharmaceutical Cash Flow from Operations for the last 12 months ending September 09, 2018 was $-105m a 36.33% decrease of -38m year over year
  • Arena Pharmaceutical Annual Cash Flow from Operations for 2017 was $-67m a 6.76% decrease of -5m from 2016
  • Arena Pharmaceutical Annual Cash Flow from Operations for 2016 was $-62m a -57.89% increase of 36m from 2015
  • Arena Pharmaceutical Annual Cash Flow from Operations for 2015 was $-98m a -3.35% increase of 3m from 2014
Other Cash Flow Metrics:
  • Arena Pharmaceutical Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-18m a 99.28% decrease of -18m year over year
  • Arena Pharmaceutical Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Cash Flow from Operations Data

09/2018$-31m
06/2018$-38m
03/2018$-30m
09/2017$-18m
06/2017$-26m
03/2017$-16m
09/2016$-20m
06/2016$-16m
03/2016$-18m
12/2015$-25m

Annual ARNA Cash Flow from Operations Data

2017$-67m
2016$-62m
2015$-98m
2014$-101m
2013$73m
2012$-44m
2011$-78m
2010$-52m
2009$-156m
2008$-191m